Annual CFF
$4.25 M
-$28.35 M-86.96%
June 30, 2022
Summary
- As of February 10, 2025, ENOB annual cash flow from financing activities is $4.25 million, with the most recent change of -$28.35 million (-86.96%) on June 30, 2022.
- During the last 3 years, ENOB annual CFF has fallen by -$1.77 million (-29.39%).
Performance
ENOB Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFF
$2.11 M
+$2.58 M+551.91%
March 31, 2023
Summary
- As of February 10, 2025, ENOB quarterly cash flow from financing activities is $2.11 million, with the most recent change of +$2.58 million (+551.91%) on March 31, 2023.
- Over the past year, ENOB quarterly CFF has increased by +$1.88 million (+818.78%).
Performance
ENOB Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFF
$4.34 M
+$1.88 M+76.45%
March 31, 2023
Summary
- As of February 10, 2025, ENOB TTM cash flow from financing activities is $4.34 million, with the most recent change of +$1.88 million (+76.45%) on March 31, 2023.
- Over the past year, ENOB TTM CFF has dropped by -$28.05 million (-86.61%).
Performance
ENOB TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
ENOB Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -87.0% | +818.8% | -86.6% |
| 3 y3 years | -29.4% | -66.0% | -62.4% |
| 5 y5 years | -22.8% | -82.3% | -18.5% |
ENOB Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -87.0% | at low | -28.5% | -122.1% | -87.8% | -43.3% |
| 5 y | 5-year | -87.0% | at low | -92.8% | -122.1% | -87.8% | -43.3% |
| alltime | all time | -87.0% | -100.0% | -92.8% | -122.1% | -87.8% | -100.0% |
Enochian Biosciences Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | $2.11 M(-551.9%) | $4.34 M(+76.4%) |
| Dec 2022 | - | -$466.60 K(-128.7%) | $2.46 M(-58.2%) |
| Sep 2022 | - | $1.63 M(+51.8%) | $5.88 M(+38.2%) |
| Jun 2022 | $4.25 M(-87.0%) | $1.07 M(+366.3%) | $4.25 M(-86.9%) |
| Mar 2022 | - | $229.50 K(-92.2%) | $32.38 M(-9.0%) |
| Dec 2021 | - | $2.95 M(>+9900.0%) | $35.59 M(+9.2%) |
| Sep 2021 | - | $0.00(-100.0%) | $32.60 M(0.0%) |
| Jun 2021 | $32.60 M(+352.8%) | $29.20 M(+749.2%) | $32.60 M(+859.3%) |
| Mar 2021 | - | $3.44 M(-8612.4%) | $3.40 M(-44.8%) |
| Dec 2020 | - | -$40.40 K(<-9900.0%) | $6.16 M(-0.7%) |
| Sep 2020 | - | $0.00(0.0%) | $6.20 M(-13.9%) |
| Jun 2020 | $7.20 M(+19.6%) | $0.00(-100.0%) | $7.20 M(-37.5%) |
| Mar 2020 | - | $6.20 M(>+9900.0%) | $11.52 M(+116.5%) |
| Dec 2019 | - | $0.00(-100.0%) | $5.32 M(-24.2%) |
| Sep 2019 | - | $1.00 M(-76.9%) | $7.02 M(+16.6%) |
| Jun 2019 | $6.02 M(-64.0%) | $4.32 M(>+9900.0%) | $6.02 M(+254.1%) |
| Mar 2019 | - | $0.00(-100.0%) | $1.70 M(-87.5%) |
| Dec 2018 | - | $1.70 M(>+9900.0%) | $13.60 M(-18.6%) |
| Sep 2018 | - | $0.00(0.0%) | $16.72 M(+0.0%) |
| Jun 2018 | $16.71 M(+203.5%) | $0.00(-100.0%) | $16.71 M(-23.4%) |
| Mar 2018 | - | $11.90 M(+147.1%) | $21.81 M(+119.0%) |
| Dec 2017 | - | $4.82 M(<-9900.0%) | $9.96 M(+93.7%) |
| Sep 2017 | - | -$4500.00(-100.1%) | $5.14 M(-6.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2017 | $5.51 M(>+9900.0%) | $5.09 M(+9545.6%) | $5.51 M(+1231.1%) |
| Mar 2017 | - | $52.80 K(>+9900.0%) | $413.70 K(+14.6%) |
| Dec 2016 | - | $0.00(-100.0%) | $360.90 K(0.0%) |
| Sep 2016 | - | $360.90 K(>+9900.0%) | $360.90 K(>+9900.0%) |
| Jun 2016 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2015 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Sep 2015 | - | $0.00(0.0%) | $5.28 M(-9.0%) |
| Mar 2015 | - | $0.00(-100.0%) | $5.80 M(-13.0%) |
| Dec 2014 | $6.67 M(>+9900.0%) | $5.28 M(+896.0%) | $6.67 M(+378.9%) |
| Sep 2014 | - | $530.20 K(-7463.9%) | $1.39 M(+59.7%) |
| Jun 2014 | - | -$7200.00(-100.8%) | $872.00 K(-0.9%) |
| Mar 2014 | - | $866.00 K(>+9900.0%) | $879.70 K(+3775.3%) |
| Dec 2013 | - | $3700.00(-61.1%) | $22.70 K(-14.3%) |
| Sep 2013 | - | $9500.00(+1800.0%) | $26.50 K(+1.9%) |
| Jun 2013 | - | $500.00(-94.4%) | $26.00 K(-28.8%) |
| Mar 2013 | $36.50 K(-5.2%) | $9000.00(+20.0%) | $36.50 K(+12.3%) |
| Dec 2012 | - | $7500.00(-16.7%) | $32.50 K(+14.0%) |
| Sep 2012 | - | $9000.00(-18.2%) | $28.50 K(-36.0%) |
| Jun 2012 | - | $11.00 K(+120.0%) | $44.50 K(+15.6%) |
| Mar 2012 | $38.50 K(+14.9%) | $5000.00(+42.9%) | $38.50 K(+14.9%) |
| Dec 2011 | $33.50 K | $3500.00(-86.0%) | $33.50 K(+11.7%) |
| Sep 2011 | - | $25.00 K(+400.0%) | $30.00 K(+500.0%) |
| Jun 2011 | - | $5000.00 | $5000.00 |
FAQ
- What is Enochian Biosciences annual cash flow from financing activities?
- What is the all time high annual CFF for Enochian Biosciences?
- What is Enochian Biosciences annual CFF year-on-year change?
- What is Enochian Biosciences quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Enochian Biosciences?
- What is Enochian Biosciences quarterly CFF year-on-year change?
- What is Enochian Biosciences TTM cash flow from financing activities?
- What is the all time high TTM CFF for Enochian Biosciences?
- What is Enochian Biosciences TTM CFF year-on-year change?
What is Enochian Biosciences annual cash flow from financing activities?
The current annual CFF of ENOB is $4.25 M
What is the all time high annual CFF for Enochian Biosciences?
Enochian Biosciences all-time high annual cash flow from financing activities is $32.60 M
What is Enochian Biosciences annual CFF year-on-year change?
Over the past year, ENOB annual cash flow from financing activities has changed by -$28.35 M (-86.96%)
What is Enochian Biosciences quarterly cash flow from financing activities?
The current quarterly CFF of ENOB is $2.11 M
What is the all time high quarterly CFF for Enochian Biosciences?
Enochian Biosciences all-time high quarterly cash flow from financing activities is $29.20 M
What is Enochian Biosciences quarterly CFF year-on-year change?
Over the past year, ENOB quarterly cash flow from financing activities has changed by +$1.88 M (+818.78%)
What is Enochian Biosciences TTM cash flow from financing activities?
The current TTM CFF of ENOB is $4.34 M
What is the all time high TTM CFF for Enochian Biosciences?
Enochian Biosciences all-time high TTM cash flow from financing activities is $35.59 M
What is Enochian Biosciences TTM CFF year-on-year change?
Over the past year, ENOB TTM cash flow from financing activities has changed by -$28.05 M (-86.61%)